ESC 2026: Abbott presents positive longer-term dual ablation catheter data

Abbott’s TactiFlex Duo provides pulsed-field ablation and radiofrequency to offer greater flexibility in treating atrial fibrillation. Abbott’s TactiFlex Duo provides pulsed-field ablation and radiofrequency to offer greater flexibility in treating atrial fibrillation. TactiFlex Duo represents an advancement on Abbott’s TactiFlex AF, a radiofrequency ablation-only catheter that secured FDA clearance in May 2023. Credit: Sundry Photography/Shutterstock.com New data from Abbott has demonstrated longer-term safety and effectiveness of its TactiFlex Duo ablation catheter in treating atrial fibrillation (AFib), building on the system’s previous six-month clinical outcomes data. Currently an investigational device in the US, TactiFlex Duo provides both pulse-field ablation (PFA) and…

Source: Clinical Trials Arena